Skip to main content
SpringerLink
Log in

Longer treatment time and lower radiation doses—an alternative for Graves’ ophthalmopathy treatment

  • Letter to the Editor
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 25 April 2022

The Original Article was published on 16 April 2021

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Weissmann T, Lettmaier S, Donaubauer AJ, Bert C, Schmidt M, Kruse F et al (2021) Low- vs. high-dose radiotherapy in Graves’ ophthalmopathy: a retrospective comparison of long-term results. Strahlenther Onkol. https://doi.org/10.1007/s00066-021-01770-9

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gerling J, Kommerell G, Henne K, Laubenberger J, Schulte-Monting J, Fells P (2003) Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind comparison between 2.4 and 16 Gy. Int J Radiat Oncol Biol Phys 55(1):182–189. https://doi.org/10.1016/s0360-3016(02)03795-1

    Article  PubMed  Google Scholar 

  3. Mourits MP, van Kempen-Harteveld ML, Garcia MB, Koppeschaar HP, Tick L, Terwee CB (2000) Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study. Lancet 355(9214):1505–1509. https://doi.org/10.1016/S0140-6736(00)02165-6

    Article  CAS  PubMed  Google Scholar 

  4. Cardoso CC, Giordani AJ, Wolosker AM, Souhami L, Manso PG, Dias RS et al (2012) Protracted hypofractionated radiotherapy for Graves’ ophthalmopathy: a pilot study of clinical and radiologic response. Int J Radiat Oncol Biol Phys 82(3):1285–1291. https://doi.org/10.1016/j.ijrobp.2010.09.015

    Article  PubMed  Google Scholar 

  5. Kahaly GJ, Rosler HP, Pitz S, Hommel G (2000) Low- versus high-dose radiotherapy for Graves’ ophthalmopathy: a randomized, single blind trial. J Clin Endocrinol Metab 85(1):102–108. https://doi.org/10.1210/jcem.85.1.6257

    Article  CAS  PubMed  Google Scholar 

  6. Guler OC, Onal C, Arslan G (2016) Graves’ ophthalmopathy treated with protracted hypofractionated low-dose adaptive radiotherapy: case report and review of the literature. Wien Klin Wochenschr 128(7–8):299–303. https://doi.org/10.1007/s00508-015-0870-z

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Adana Dr. Turgut Noyan Research and Treatment Center, Baskent University Faculty of Medicine, 01120, Adana, Turkey

    Cem Onal & Ozan Cem Guler

  2. Department of Radiation Oncology, Baskent University Faculty of Medicine, Ankara, Turkey

    Cem Onal

Authors
  1. Cem Onal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ozan Cem Guler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Cem Onal.

Ethics declarations

Conflict of interest

C. Onal and O.C. Guler declare that they have no competing interests.

Additional information

This comment refers to the article available at https://doi.org/10.1007/s00066-021-01770-9.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onal, C., Guler, O.C. Longer treatment time and lower radiation doses—an alternative for Graves’ ophthalmopathy treatment. Strahlenther Onkol 198, 663–664 (2022). https://doi.org/10.1007/s00066-021-01852-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-021-01852-8

Search

Navigation